Ledger.Open graph →
SEC Form D · filed May 13, 2024

Aeovian Pharmaceuticals, Inc

Offering
$50.4M
Sold
$50.4M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
Berkeley, CA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (22)

John J. Kincaid · Berkeley, CAExecDavis J. Ryman · Berkeley, CAExecRichard J. Gaster · Berkeley, CADirectorNils J. Regge · Berkeley, CADirectorAllison J. Hulme · Berkeley, CAExec · DirectorWilliam J. Greene · Berkeley, CADirectorDavis J. Ryman · Berkeley, CAExecRichard J. Gaster · Berkeley, CADirectorAllison J. Hulme · Berkeley, CAExec · DirectorNils J. Regge · Berkeley, CADirectorJohn J. Kincaid · Berkeley, CAExecWilliam J. Greene · Berkeley, CADirectorMatthew J. Plunkett · Berkeley, CAExecLars C. Ekm · Berkeley, CADirectorRima C. Simson · New York, NYExecMark Attanasio · Culver City, CADirectorScott Carson · Park City, UTDirectorDavid Licata · Culver City, CAExec · DirectorRob Mlenek · Bloomington, MNExecAlex M. Page · New York, NYDirectorMatthew J. Plunkett · Berkeley, CAExecLars C. Ekm · Berkeley, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗